|Update on Power 3 Medical Products (PWRM)|
|By Leonard H. Berner|
|Wednesday, 25 November 2009 03:00|
Many investors have been asking why PWRM did not announce news from the conference in China last week. Did they leave us holding the bag?
As we reported last Wednesday, Dr. Ira Goldknopf, the Chief Scientific Officer of Power 3 Medical Products (PWRM), was scheduled to present a keynote address & chair a session on "Biomarkers & Diagnosticsin Personalized Medicine" at the BIT Life Sciences 2nd International Congress Expo of Molecular Diagnostics in Beijing, China.
We spoke yesterday afternoon with Kenneth Bosket, the very kind gentleman who handles investors relations at PWRM. He informed me that Dr. Goldknopf has just returned from China and that he would be emailing him the full text of his speech today for dissemination.
In addition, Bosket said he will be sending a copy of the text directly to us upon his receipt.
Helen Park, the CEO of PWRM, had told BioMedReports' M.E. Garza last week, that Goddknopf would be reporting "new information" on the results of their recently completed Phase I Clinical Trials for Alzheimer's & Parkinson's diseases blood diagnostic tests which had shown better than expected results. Shares ran up substantitally upon the news, but no press release was issued by the company after the presentation.
We will let you know all the details as soon as we receive them. Mr. Bosket said the company hopes to release the text to us by Friday, and we will share that with you as soon as we receive it.
We welcome Leonard H. Berner as a new reporter/analyst for BioMedReports. Mr. Berner has been a long time trader/investor in the sector and his solid fundamental analysis skills and hard hitting questions will no doubt win readers of our portal over in the coming months.